Tissue Regeneration Technologies – A four patient pilot trial was conducted in 2018 including four (4) subjects with an average age of 62 (range 57 – 71). All subjects reported typical symptoms of low testosterone.
Tissue Regeneration Technologies – A four patient pilot trial was conducted in 2018 including four (4) subjects with an average age of 62 (range 57 – 71). All subjects reported typical symptoms of low testosterone.